Engenco Limited (ASX:EGN) Receives Increased Takeover Offer
Elph Investments increases its takeover offer for Engenco Limited (ASX:EGN) from $0.305 to $0.31 per share.
Tag: Regulatory News & Compliance
Noxopharm Limited (ASX:NOX) Receives Approval for HERACLES Clinical Trial
Noxopharm Limited (ASX:NOX) receives ethics approval for its innovative HERACLES clinical trial, advancing new treatments for chronic inflammatory diseases.
St Barbara Limited (ASX:SBM) Confirms 15-Mile Processing Hub Development
St Barbara Limited (ASX:SBM) confirms a 3 Mtpa processing hub at 15-Mile, ensuring robust gold production and strong project economics.
Avecho Biotechnology Limited (ASX:AVE) Receives $1.66M R&D Tax Incentive
Avecho Biotechnology Limited (ASX:AVE) receives $1.66M under the R&D Tax Incentive to support its Phase III insomnia trial and commercialization efforts.
TerraCom Limited (ASX:TER) Reaches Agreement with ASIC on Whistleblower Proceedings
TerraCom Limited (ASX:TER) has settled ASIC whistleblower proceedings with a $7.5 million penalty, pending court approval.
Recce Pharmaceuticals (ASX:RCE) Secures China Patent for Anti-Infectives
Recce Pharmaceuticals (ASX:RCE) secures a China Patent for its RECCE® anti-infectives, enhancing its global intellectual property portfolio.
Victory Metals Limited (ASX:VTM) Responds to ASX Query
Victory Metals Limited (ASX:VTM) addresses ASX’s query on significant trading activity and confirms compliance with listing rules.
Dimerix (ASX:DXB) Successfully Completes IDMC Review for ACTION3 Phase 3 Trial
Dimerix (ASX:DXB) successfully completes IDMC review of ACTION3 Phase 3 trial, affirming DMX-200’s safety profile.
Dexus (ASX:DXS) Secures Injunction in APAC Governance Dispute
Dexus (ASX:DXS) secures an injunction against APAC, safeguarding shareholder rights until an August court ruling.
James Hardie Industries plc (ASX:JHX) Releases Annual Asbestos Liability Valuation
James Hardie Industries plc (ASX:JHX) unveils its annual valuation of asbestos-related liabilities, showing an increase to $1,472.4 million and outlining significant financial and regulatory updates.